We use advanced imaging technology to detect disease biomarkers throughout the eye

1-TEST.png

1 / Eye Examination

We take images by combining standard equipment available in most eye clinics with a specialized camera -- this means that the experience is familiar and comfortable.

2-IMG.png

2 / Data-Rich Images

Our hyperspectral camera can captures data-rich images with a broad spectrum of information,  providing the basis for detailed analysis of a large area for more accurate results

3-AI.png

3 / Artificial Intelligence

Our AI identifies early signs of Alzheimer’s disease by comparing the captured images to others where the biological signatures associated with these neurodegenerative diseases are present.

cb_retiscan_04.JPG

Our Solution

We partner with pharmaceutical companies and leading research institutions to accelerate research and integrate seamlessly into the clinical workflow

Our Benefits

Existing tests used to detect the hallmark pathologies of Alzheimer’s disease are prohibitively invasive and costly. RetiSpec offers a non-invasive affordable optical technology that works with existing Optometry equipment and can be completed as part of a routine eye exam.